p53 Plays a Regulatory Role in Differentiation and Apoptosis of Central Nervous System-Associated Cells

REFERENCES

• Allcutt, D., M. Berry, and J. Sievers. 1984. A qualitative comparison of retinal ganglion cell axons to optic nerve crush in neonate and adult mice. Dev. Brain Res. 16:231–240.
   Google Scholar
• Arakawa, Y., M. Sendtner, and H. Thoenen. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci. 10:3507–3515.
   PubMed Web of Science ®Google Scholar
• Armstrong, J. F., M. H. Kaufman, D. J. Harrison, and A. R. Clark. 1995. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:931–936.
   PubMed Web of Science ®Google Scholar
• Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915.
   PubMed Web of Science ®Google Scholar
• Barres, B. A., I. K. Hart, H. S. Coles, J. F. Burne, J. T. Voyvodic, W. D. Richardson, and M. C. Raff. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31–46.
   PubMed Web of Science ®Google Scholar
• Barres, B. A., M. C. Raff, F. Gaese, I. Bartke, G. Dechant, and Y. A. Barde. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature (London) 367:371–375.
   PubMed Web of Science ®Google Scholar
• Barres, B. A., R. Schmid, M. Sendtner, and M. C. Raff. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283–295.
   PubMedGoogle Scholar
• Bottenstein, J. E., and G. H. Sato. 1979. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514–517.
   PubMed Web of Science ®Google Scholar
• Bottenstein, J. E., and G. H. Sato (ed.). 1985. Cell culture in the neuro-sciences, p. 3–44. Plenum Press, New York.
   Google Scholar
• Buchman, V. L., and A. M. Davies. 1993. Different neurotrophins are expressed and act in a developmental sequence to promote the survival of embryonic sensory neurons. Development 118:989–1001.
   PubMed Web of Science ®Google Scholar
• Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (London) 370:220–223.
   PubMed Web of Science ®Google Scholar
• Chen, P.-L., Y. Chen, R. Bookstein, and W.-H. Lee. 1990. Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576–1580.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bio-chem. 162:156–159.
   Google Scholar
• Cowan, W. M. 1973. Neuronal death as a regulative mechanism in the control of cell number in the nervous system, p. 19–41. In M. Rockstein (ed.), Development and aging of the nervous system. Academic Press, New York.
   Google Scholar
• Cowan, W. M., J. W. Fawcett, D. D. O’Leary, and B. B. Stanfield. 1984. Regressive events in neurogenesis. Science 225:1258–1265.
   PubMed Web of Science ®Google Scholar
• Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772–5781.
   PubMed Web of Science ®Google Scholar
• Donehower, L. A., and A. Bradley. 1993. The tumor suppressor p53. Biochim. Biophys. Acta 1155:181–205.
   PubMed Web of Science ®Google Scholar
• Dugaiczyk, A., J. A. Haron, E. M. Stone, O. E. Dennison, K. N. Rothblum, and R. J. Schwartz. 1983. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry 22:1605–1613.
   PubMed Web of Science ®Google Scholar
• Duguid, J. R., C. W. Bohmot, N. Liu, and W. W. Tourtellotte. 1989. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7260–7264.
   PubMed Web of Science ®Google Scholar
• Eizenberg, O., A. Faber-Elman, E. Gottlieb, M. Oren, V. Rotter, and M. Schwartz. 1995. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14:1136–1144.
   PubMed Web of Science ®Google Scholar
• Erlich, H. A. 1989. PCR technology: principles and applications for DNA amplification. Stockton Press, New York.
   Google Scholar
• Feinberg, A., and B. Vogelstein. 1984. A technique for radiolabeling restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:266–267.
   PubMed Web of Science ®Google Scholar
• Feinstein, E., R. P. Gale, J. Reed, and E. Canaani. 1992. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 7:1853–1857.
   PubMedGoogle Scholar
• Ferrer, I., A. Tortosa, E. Condom, R. Blanco, A. Macaya, and A. Planas. 1994. Increased expression of bcl-2 immunoreactivity in the developing cerebral cortex of the rat. Neurosci. Lett. 179:13–16.
   PubMedGoogle Scholar
• Gannon, J. V., and D. P. Lane. 1991. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature (London) 349:802–806.
   PubMedGoogle Scholar
• García-Valenzuela, E., W. Gorczyca, Z. Darzynkiewicz, and S. C. Sherma. 1994. Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol. 25:431–438.
   PubMedGoogle Scholar
• Ginsberg, D., D. Michael-Michalovitz, D. Ginsberg, and M. Oren. 1991. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol. Cell. Biol. 11:582–585.
   PubMedGoogle Scholar
• Goslin, K., and G. Banker. 1991. Rat hippocampal neurons in low density culture, p. 251–281. In G. Banker and K. Goslin (ed.), Culturing nerve cells. MIT Press, Cambridge, Mass.
   Google Scholar
• Gottlieb, E., R. Haffner, T. von Ruden, E. W. Wagner, and M. Oren. 1994. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13:1368–1374.
   PubMed Web of Science ®Google Scholar
• Grafstein, B., and N. A. Ingoglia. 1982. Intracranial transection of the optic nerve in adult mice: preliminary observations. Exp. Neurol. 76:318–330.
   PubMed Web of Science ®Google Scholar
• Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 antigens. J. Virol. 39:861–869.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543–546.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., and T. A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629–633.
   PubMed Web of Science ®Google Scholar
• Haupt, Y., S. Rowan, E. Shaulian, K. H. Vousden, and M. Oren. 1995. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9:2170–2183.
   PubMed Web of Science ®Google Scholar
• Johnson, G. D., R. S. Davidson, K. C. McNamee, D. G. Russell, and E. J. Holborow. 1982. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods 55:231–242.
   PubMed Web of Science ®Google Scholar
• Kane, D. J., T. A. Sarafin, R. Anton, H. Hahn, E. Butler-Gralla, V. J. Selverstone, T. Ord, and D. E. Bredesen. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274–1277.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 in the cellular response to DNA damage. Cancer Res. 51:6304–6311.
   PubMed Web of Science ®Google Scholar
• Korsmeyer, S. J., J. R. Shutter, D. J. Veis, D. E. Merry, and Z. N. Oltvai. 1993. Bcl-2/bax: a rheostat that regulates an antioxidant pathway and cell death. Semin. Cancer Biol. 4:327–332.
   PubMed Web of Science ®Google Scholar
• Krajewski, S., J. K. Mai, M. Krajewska, M. Sikorska, M. J. Mossakowski, and J. C. Reed. 1995. Upregulation of bax protein levels in neurons following cerebral ischemia. J. Neurosci. 15:6364–6376.
   PubMed Web of Science ®Google Scholar
• Lane, D. P. 1992. Worrying about p53. Curr. Biol. 2:581–583.
   PubMedGoogle Scholar
• Lehrach, H., D. Diomond, J. M. Wosney, and H. Boedtker. 1977. RNA molecular weight determination by gel electrophoresis under denaturing conditions: a critical reexamination. Biochemistry 16:4743–4751.
   PubMed Web of Science ®Google Scholar
• Livingstone, L. R., A. White, J. Sprouse, E. Livanson, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923–935.
   PubMed Web of Science ®Google Scholar
• Louis, J.-C., E. Magal, S. Takayama, and S. Varon. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689–692.
   PubMed Web of Science ®Google Scholar
• Mah, S. P., L. T. Zhong, Y. Liu, A. Roghani, R. H. Edwards, and D. E. Bredesen. 1993. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1183–1186.
   PubMed Web of Science ®Google Scholar
• Maltzman, W., M. Oren, and A. J. Levine. 1981. The structural relationships between 54000-molecular weight cellular tumor antigens detected in viral-and nonviral-transformed cells. Virology 112:145–156.
   PubMedGoogle Scholar
• Martíınez, J., I. Georgoff, J. Martíınez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature sensitive-mutant p53 protein. Genes Dev. 5:151–159.
   PubMedGoogle Scholar
• McCarthy, K. D., and J. J. deVellis. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:890–902.
   PubMed Web of Science ®Google Scholar
• McKinnon, R. D., T. Matsui, M. Dubois-Dalcq, and S. A. Aaronson. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603–614.
   PubMed Web of Science ®Google Scholar
• Mercer, W. E., M. Amin, G. J. Sauve, E. Appella, S. J. Ullrich, and J. Romano. 1990. Wild-type p53 is antiproliferative in SV40-transformed hamster cells. Oncogene 5:973–980.
   PubMed Web of Science ®Google Scholar
• Mercer, W. E., M. T. Shields, M. Amin, G. J. Sauve, E. Appella, and S. J. Ullrich. 1990. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA 87:6166–6170.
   PubMed Web of Science ®Google Scholar
• Merry, D. E., D. J. Veis, W. F. Hickey, and S. J. Korsmeyer. 1994. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301–311.
   PubMed Web of Science ®Google Scholar
• Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671–680.
   PubMed Web of Science ®Google Scholar
• Misantone, L. J., M. Gershenbaum, and M. Murray. 1984. Viability of retinal ganglion cells after optic nerve crush in rats. J. Neurocytol. 13:449–465.
   PubMedGoogle Scholar
• Miyashita, T., S. Krajewski, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax in gene expression in vitro and in vivo. Oncogene 9:1799–1805.
   PubMed Web of Science ®Google Scholar
• Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293–299.
   PubMed Web of Science ®Google Scholar
• Moll, U. M., M. LaQuaglia, J. Benard, and G. Riou. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblas-tomas but not in differentiated tumors. Proc. Natl. Acad. Sci. USA 92:4407–4411.
   PubMed Web of Science ®Google Scholar
• Moll, U. M., G. Riou, and A. J. Levine. 1992. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA 89:7262–7266.
   PubMed Web of Science ®Google Scholar
• Noble, M., K. Murray, P. Strobant, M. D. Waterfield, and P. Riddle. 1988. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature (London) 333:560–562.
   PubMed Web of Science ®Google Scholar
• Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimer-izes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609–619.
   PubMed Web of Science ®Google Scholar
• Oppenhaim, R. W. 1981. Neuronal cell death and some related regressive phenomena during neurogenesis: a selective historical review and progress report, p. 74–133. In W. M. Cowan (ed.), Studies in developmental neuro- biology: essays in honor of Victor Hamburger. Oxford University Press, New York.
   Google Scholar
• Oppenhaim, R. W. 1991. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:453–501.
   PubMedGoogle Scholar
• Quigley, H. A., R. W. Nickells, L. A. Kerrigan, M. E. Pease, D. J. Thibault, and D. J. Zack. 1995. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Visual Sci. 36:774–786.
   PubMed Web of Science ®Google Scholar
• Raff, M. C., B. A. Barres, J. F. Burne, H. S. Coles, Y. Ishizaki, and M. D. Jacobson. 1993. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695–700.
   PubMed Web of Science ®Google Scholar
• Raff, M. C., R. H. Miller, and M. Noble. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (London) 303:390–396.
   PubMed Web of Science ®Google Scholar
• Reed, M., Y. Wang, G. Mayr, M. E. Anderson, J. F. Schwedes, and P. Tegtmeyer. 1993. p53 domains: suppression, transformation, and transacti-vation. Gene Expr. 3:95–107.
   PubMedGoogle Scholar
• Richardson, W. D., N. Pringle, M. J. Mosley, B. Watermark, and M. Dubois-Dalcq. 1988. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53:309–319.
   PubMed Web of Science ®Google Scholar
• Rodríguez, M., B. W. Scheithauer, G. Forbes, and P. J. Kelly. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin. Proc. 68:627–636.
   PubMedGoogle Scholar
• Sah, V. P., L. D. Attardi, G. J. Mulligan, B. O. Williams, R. T. Bronson, and T. Jacks. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 19:175–180.
   Google Scholar
• Sakhi, S., A. Bruce, N. Sun, G. Tocco, M. Baudry, and S. S. Schreiber. 1994. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA 91:7525–7529.
   PubMedGoogle Scholar
• Selvakumaran, M., H.-K. Lin, T. Miyashita, H. G. Wang, S. Krajewski, J. C. Reed, B. Hoffman, and D. Liebermann. 1994. Immediate early up-regulation of bax expression by p53 but not TGF-β1: a paradigm for distinct apoptotic pathways. Oncogene 9:1791–1798.
   PubMed Web of Science ®Google Scholar
• Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12:5581–5592.
   PubMed Web of Science ®Google Scholar
• Shaulsky, G., A. Ben-Ze’ev, and V. Rotter. 1990. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1707–1711.
   PubMedGoogle Scholar
• Shaulsky, G., N. Goldfinger, A. Ben-Ze’ev, and V. Rotter. 1990. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10:6565–6577.
   PubMed Web of Science ®Google Scholar
• Shaulsky, G., N. Goldfinger, A. Peled, and V. Rotter. 1991. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 88:8982–8986.
   PubMedGoogle Scholar
• Shaulsky, G., N. Goldfinger, M. S. Tosky, A. J. Levine, and V. Rotter. 1991. Nuclear localization is essential for the activity of p53 protein. Oncogene 6:2055–2065.
   PubMed Web of Science ®Google Scholar
• Shaw, P., R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89:4495–4499.
   PubMed Web of Science ®Google Scholar
• Temple, S., and M. C. Raff. 1986. Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell 44:773–779.
   PubMed Web of Science ®Google Scholar
• Vantini, G., and S. D. Skaper. 1992. Neurotrophic factors: from physiology to pharmacology? Pharmacol. Res. 26:1–15.
   Google Scholar
• Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817–2830.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach, E., D. Ginsberg, and M. Oren. 1993. The role of tumor suppressor genes in apoptosis, p. 187–202. In M. Lavin and D. Watters (ed.), Programmed cell death. Harwood, Chur, Switzerland.
   Google Scholar
• Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (London) 352:345–347.
   PubMed Web of Science ®Google Scholar
• Zhong, L.-T., T. Sarafian, D. J. Kane, A. C. Charles, S. P. Mah, R. H. Edwards, and D. E. Bredesen. 1993. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 90:4533–4537.
   PubMed Web of Science ®Google Scholar